自動注射器の世界市場規模調査＆予測：用途、タイプ、エンドユーザー別、地域分析、2023-2030年

自動注射器の世界市場は、2022年に約80億米ドルと評価され、予測期間2023-2030年には16.05％以上の健全な成長率で成長すると予測されています。

自動注射器は、あらかじめ充填された注射器システムを通じて特定の薬剤を1回分投与するように設計された医療機器です。一般的に、関節リウマチ、多発性硬化症、アナフィラキシー、定期的な注射を必要とするその他の慢性疾患などの症状に対して、患者が薬剤を自己投与するために使用されます。この市場には、手動モデルや自動モデルを含む様々なタイプの自動注射器があり、便利で効率的なドラッグデリバリーソリューションを求めるヘルスケアプロバイダー、患者、製薬会社に貢献しています。市場成長の原動力は、患者の利便性に対する需要の増加、慢性疾患や生活習慣病の罹患率の上昇、技術の進歩です。

例えば、世界保健機関（WHO）によると、慢性疾患の有病率は2020年までに57％増加すると予測されており、この急増の約60％は新興市場で見込まれています。慢性疾患は、世界的に障害と罹患の最大の原因となっています。Globocan 2020報告書によると、世界で新たにがんと診断された患者数は1,929万2,789人で、がんに関連する死亡者数は995万8,133人でした。さらに、2021年12月に国際糖尿病連合が発表したデータによると、糖尿病患者は20～79歳の成人で約5億3,700万人にのぼり、2030年には6億4,300万人、2045年には7億8,300万人に達すると予測されています。さらに、最近の様々な研究によると、関節リウマチの治療を自己注射器で受けている患者のかなりの割合が、外部投与に頼っている患者に比べて快適であり、転帰も改善されていると報告しています。さらに、市場プレイヤーの積極的な取り組みが市場拡大を後押ししています。例えば、2022年3月、SEVER Life Sciencesの子会社であるNORDIC PHARMAは、メトトレキサート自動注射薬Nordimetの新薬承認申請をカナダ保健省に提出しました。Nordimetは、重度の活動性関節リウマチ（RA）の治療と、代替療法に反応しない成人の重度の難治性乾癬の症状コントロールを目的としています。このような薬剤の承認が見込まれることで、市場の成長は加速するものと思われます。しかし、代替ドラッグデリバリーへの嗜好や規制上のハードルが、2023～2030年の予測期間を通じて市場成長を阻害します。

自動注射器の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、予測期間を通じて世界の使い捨て自動注射器市場のかなりの部分を占めており、アジア太平洋が僅差で追随する最も急成長している地域であることが期待されています。同地域の市場支配力は、技術的に先進的な製品の早期導入、一貫した製品承認、慢性疾患の罹患率の増加などの要因によるもので、これらすべてが市場拡大に寄与しています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 自動注射器の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 自動注射器の世界市場力学

• 自動注射器市場の影響分析（2020-2030年）
  • 市場促進要因
    • 患者の利便性に対する需要の増加
    • 慢性疾患と生活習慣病の増加
    • 技術の進歩
  • 市場の課題
    • 代替ドラッグデリバリーへの志向
    • 規制上のハードル
  • 市場機会
    • 患者の利便性に対する需要の増加
    • 医療用品に対する需要の増加

第4章 自動注射器の世界市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 自動注射器の世界市場：タイプ別

• 市場スナップショット
• 自動注射器の世界市場：タイプ別、実績 - ポテンシャル分析
• 自動注射器の世界市場タイプ別推定・予測2020-2030年
• 自動注射器市場、サブセグメント分析
  • 使い捨て自動注射器
  • 再利用可能な自動注射器

第6章 自動注射器の世界市場：用途別

• 市場スナップショット
• 自動注射器の世界市場：用途別、実績 - ポテンシャル分析
• 自動注射器の世界市場、用途別推定・予測2020-2030年
• 自動注射器市場、サブセグメント分析
  • 関節リウマチ
  • 多発性硬化症
  • アナフィラキシー
  • その他の用途

第7章 自動注射器の世界市場：エンドユーザー別

• 市場スナップショット
• 自動注射器の世界市場：エンドユーザー別、実績 - ポテンシャル分析
• 自動注射器の世界市場：エンドユーザー別推定・予測2020～2030年
• 自動注射器市場、サブセグメント分析
  • 在宅医療
  • 病院と診療所
  • その他のエンドユーザー

第8章 自動注射器の世界市場：地域別分析

• 主要国
• 新興国
• 自動注射器市場、地域別市場スナップショット
• 北米
  • 米国
    • タイプ別推定・予測、2020-2030年
    • アプリケーションの推定・予測、2020-2030年
    • エンドユーザー別の推定・予測、2020～2030年
  • カナダ
• 欧州自動注射器市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋自動注射器市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの自動注射器市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Dickinson and Company
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Abbvie Inc
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Becton, Dickinson and Company
  • Biogen Inc
  • Eli Lilly and Company
  • Novartis AG
  • Teva Pharmaceuticals
  • Ypsomed AG

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1.Global Autoinjectors Market, report scope
• TABLE 2.Global Autoinjectors Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3.Global Autoinjectors Market estimates & forecasts by Type 2020-2030 (USD Billion)
• TABLE 4.Global Autoinjectors Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 5.Global Autoinjectors Market estimates & forecasts by End-user 2020-2030 (USD Billion)
• TABLE 6.Global Autoinjectors Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7.Global Autoinjectors Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8.Global Autoinjectors Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9.Global Autoinjectors Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10.Global Autoinjectors Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11.Global Autoinjectors Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12.Global Autoinjectors Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13.Global Autoinjectors Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14.Global Autoinjectors Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15.Global Autoinjectors Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16.U.S. Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17.U.S. Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18.U.S. Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19.Canada Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20.Canada Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21.Canada Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22.UK Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23.UK Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24.UK Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25.Germany Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26.Germany Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27.Germany Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28.France Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29.France Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30.France Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31.Italy Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32.Italy Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33.Italy Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34.Spain Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35.Spain Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36.Spain Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37.RoE Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38.RoE Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39.RoE Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40.China Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41.China Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42.China Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43.India Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44.India Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45.India Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46.Japan Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47.Japan Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48.Japan Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49.South Korea Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50.South Korea Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51.South Korea Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52.Australia Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53.Australia Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54.Australia Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55.RoAPAC Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56.RoAPAC Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57.RoAPAC Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58.Brazil Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59.Brazil Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60.Brazil Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61.Mexico Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62.Mexico Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63.Mexico Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64.RoLA Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65.RoLA Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66.RoLA Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67.Saudi Arabia Autoinjectors Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68.South Africa Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69.RoMEA Autoinjectors Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70.List of secondary sources, used in the study of global Autoinjectors Market
• TABLE 71.List of primary sources, used in the study of global Autoinjectors Market
• TABLE 72.Years considered for the study
• TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Autoinjectors Market, research methodology
• FIG 2.Global Autoinjectors Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Autoinjectors Market, key trends 2022
• FIG 5.Global Autoinjectors Market, growth prospects 2023-2030
• FIG 6.Global Autoinjectors Market, porters 5 force model
• FIG 7.Global Autoinjectors Market, pest analysis
• FIG 8.Global Autoinjectors Market, value chain analysis
• FIG 9.Global Autoinjectors Market by segment, 2020 & 2030 (USD Billion)
• FIG 10.Global Autoinjectors Market by segment, 2020 & 2030 (USD Billion)
• FIG 11.Global Autoinjectors Market by segment, 2020 & 2030 (USD Billion)
• FIG 12.Global Autoinjectors Market by segment, 2020 & 2030 (USD Billion)
• FIG 13.Global Autoinjectors Market by segment, 2020 & 2030 (USD Billion)
• FIG 14.Global Autoinjectors Market, regional snapshot 2020 & 2030
• FIG 15.North America Autoinjectors Market 2020 & 2030 (USD Billion)
• FIG 16.Europe Autoinjectors Market 2020 & 2030 (USD Billion)
• FIG 17.Asia pacific Autoinjectors Market 2020 & 2030 (USD Billion)
• FIG 18.Latin America Autoinjectors Market 2020 & 2030 (USD Billion)
• FIG 19.Middle East & Africa Autoinjectors Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Autoinjectors Market is valued approximately USD 8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.05% over the forecast period 2023-2030. Autoinjectors are medical devices designed to deliver a single dose of a particular medication through a pre-filled syringe system. They are typically used by patients for self-administration of medications, particularly for conditions such as rheumatoid arthritis, multiple sclerosis, anaphylaxis, and other chronic diseases requiring regular injections. The market encompasses various types of autoinjectors, including manual and automated models, and serves healthcare providers, patients, and pharmaceutical companies seeking convenient and efficient drug delivery solutions. The market growth is driven by increasing Demand for Convenience of Patients, rising Incidence of Chronic and Lifestyle Diseases, technological Advancements.

For instance, As per the World Health Organization (WHO), the prevalence of chronic diseases is anticipated to increase by 57% by 2020 , with approximately 60% of this surge expected in emerging markets. Chronic diseases represent the foremost causes of disability and morbidity globally. According to the Globocan 2020 report, there were 19,292,789 new cancer cases diagnosed worldwide, resulting in 9,958,133 cancer-related deaths. Additionally, data from the International Diabetes Federation in December 2021 indicates that diabetes affects around 537 million adults aged 20 to 79. By 2030, the diabetic population is projected to reach 643 million, and by 2045, it is forecasted to climb to 783 million. Furthermore, according to various recent studies, a significant proportion of patients undergoing treatment for rheumatoid arthritis with an autoinjector reported comfort and even demonstrated improved outcomes compared to those relying on external administration. Moreover, market players' proactive initiatives are driving market expansion. For example, in March 2022, NORDIC PHARMA, a SEVER Life Sciences subsidiary, submitted a New Drug Submission to Health Canada for its methotrexate auto-injector, Nordimet, aimed at treating severe disabling active rheumatoid arthritis (RA) and providing symptomatic control of severe, recalcitrant, disabling psoriasis in adults unresponsive to alternative therapies. The anticipated approval of such medications is poised to accelerate market growth. However, preference for Alternative Drug Delivery Modes, and regulatory Hurdles stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Autoinjectors Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America commands a substantial portion of the global disposable auto-injectors market throughout the forecast period, with expectations for being the fastest-growing region, closely trailed by APAC. The region's market dominance can be attributed to factors such as the early embrace of technologically advanced products, consistent product approvals, and the increasing incidence of chronic diseases, all of which contribute to market expansion.

Major market player included in this report are:

• Dickinson and Company
• Abbvie Inc
• Amgen Inc.
• AstraZeneca Plc
• Bayer AG
• Becton, Dickinson and Company
• Biogen Inc
• Eli Lilly and Company
• Novartis AG
• Teva Pharmaceuticals
• Ypsomed AG
• Abbvie
• Amgen
• AstraZeneca
• Bayer
• Becton
• Biogen
• Eli Lilly
• Novartis
• Teva Pharmaceuticals
• Ypsomed

Recent Developments in the Market:

• In August 2023, Taisho Pharmaceutical obtained FDA approval to produce and distribute the Nanozora(R) 30 mg autoinjector, intended for treating patients with rheumatoid arthritis.
• In May 2023, Boehringer Ingelheim revealed FDA approval for the Cyltezo(R) Pen autoinjector, designed for patients with chronic inflammatory disorders.
• In May 2023, MoonLake partnered with SHL Medical to co-develop an autoinjector for the clinical and commercial distribution of MoonLake's Nanobody(R) sonelokimab.

Global Autoinjectors Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Type, Application, End-use, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Rheumatoid Arthritis
• Multiple Sclerosis
• Anaphylaxis
• Other Applications

By Application:

• Disposable Autoinjectors
• Reusable Autoinjectors

By End-use:

• Home Care Settings
• Hospital & Clinics
• Other End Users

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Autoinjectors Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Autoinjectors Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3.Autoinjectors Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Autoinjectors Market, by End-user, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Autoinjectors Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Autoinjectors Market Dynamics

• 3.1.Autoinjectors Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing Demand for Convenience of Patients
    • 3.1.1.2.Rising Incidence of Chronic and Lifestyle Diseases
    • 3.1.1.3. Technological Advancements
  • 3.1.2.Market Challenges
    • 3.1.2.1.Preference for Alternative Drug Delivery Modes
    • 3.1.2.2.Regulatory Hurdles
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Increasing demand for the convenience of patients
    • 3.1.3.2.Increased demand for medical supplies

Chapter 4.Global Autoinjectors Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Autoinjectors Market, by Type

• 5.1.Market Snapshot
• 5.2.Global Autoinjectors Market by Type, Performance - Potential Analysis
• 5.3.Global Autoinjectors Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4.Autoinjectors Market, Sub Segment Analysis
  • 5.4.1.Disposable Autoinjectors
  • 5.4.2.Reusable Autoinjectors

Chapter 6.Global Autoinjectors Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Autoinjectors Market by Application, Performance - Potential Analysis
• 6.3.Global Autoinjectors Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Autoinjectors Market, Sub Segment Analysis
  • 6.4.1.Rheumatoid Arthritis
  • 6.4.2.Multiple Sclerosis
  • 6.4.3.Anaphylaxis
  • 6.4.4.Other Applications

Chapter 7.Global Autoinjectors Market, by End-user

• 7.1.Market Snapshot
• 7.2.Global Autoinjectors Market by End-user, Performance - Potential Analysis
• 7.3.Global Autoinjectors Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
• 7.4.Autoinjectors Market, Sub Segment Analysis
  • 7.4.1.Home Care Settings
  • 7.4.2.Hospital & Clinics
  • 7.4.3.Other End Users

Chapter 8.Global Autoinjectors Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Autoinjectors Market, Regional Market Snapshot
• 8.4.North America Autoinjectors Market
  • 8.4.1.U.S. Autoinjectors Market
    • 8.4.1.1.Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End-user breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Autoinjectors Market
• 8.5.Europe Autoinjectors Market Snapshot
  • 8.5.1.U.K. Autoinjectors Market
  • 8.5.2.Germany Autoinjectors Market
  • 8.5.3.France Autoinjectors Market
  • 8.5.4.Spain Autoinjectors Market
  • 8.5.5.Italy Autoinjectors Market
  • 8.5.6.Rest of Europe Autoinjectors Market
• 8.6.Asia-Pacific Autoinjectors Market Snapshot
  • 8.6.1.China Autoinjectors Market
  • 8.6.2.India Autoinjectors Market
  • 8.6.3.Japan Autoinjectors Market
  • 8.6.4.Australia Autoinjectors Market
  • 8.6.5.South Korea Autoinjectors Market
  • 8.6.6.Rest of Asia Pacific Autoinjectors Market
• 8.7.Latin America Autoinjectors Market Snapshot
  • 8.7.1.Brazil Autoinjectors Market
  • 8.7.2.Mexico Autoinjectors Market
• 8.8.Middle East & Africa Autoinjectors Market
  • 8.8.1.Saudi Arabia Autoinjectors Market
  • 8.8.2.South Africa Autoinjectors Market
  • 8.8.3.Rest of Middle East & Africa Autoinjectors Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1. Dickinson and Company
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2. Abbvie Inc
  • 9.3.3.Amgen Inc.
  • 9.3.4. AstraZeneca Plc
  • 9.3.5.Bayer AG
  • 9.3.6. Becton, Dickinson and Company
  • 9.3.7.Biogen Inc
  • 9.3.8.Eli Lilly and Company
  • 9.3.9.Novartis AG
  • 9.3.10.Teva Pharmaceuticals
  • 9.3.11. Ypsomed AG

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption